mossreports_fb_pixel

Moss Report on Liver Cancer

Alternative & Conventional Liver Cancer Treatments (2019 Update)

“Ralph Moss performs a great service for those who want to know more about cancer, which includes a vast number of people both at present and likely long into the future.” Prof. Peter Pedersen, PhD Department of Biological Chemistry,School of Medicine, Johns Hopkins University Report on Liver Cancer
Alternative & Conventional Liver Cancer Treatment: Moss Report On Liver Cancer (Updated For 2018)
By Ralph W. Moss, PhD
What’s New In Liver Cancer Treatment For 2018
A discussion of a new study of a single-arm phase II study of proton (beam) therapy at the University ofPennsylvania, Philadelphia medical center.James Allison, PhD, is the head of immunology at the University of Texas M.D. Anderson Cancer Center, Houston. While at the University of California, Berkeley, he invented an important new class of medications called “immune checkpoint inhibitors.” Allison is currently working on combining these medications with cancer-killing viruses, such as Newcastle Disease Virus (NDV) vaccines. These are already available at several foreign clinics.One of the most significant advances of recent years has been the development and FDA approval of an anti-cancer virus vaccine, Reolysin® (pelareorep). The 2018 Moss Report discusses this new medicine and its associated clinical trials.
New Drugs For Liver Cancer In 2018
FDA expanded the indications of regorafenib (Stivarga®) to includethe treatment of patients with hepatocellular carcinoma (HCC) who had been previouslytreated with sorafenib.FDA also granted accelerated approval to nivolumab(Opdivo®)for the treatment of hepatocellular carcinoma (HCC) in patients who havebeen previously treated with sorafenib.
Liver Cancer Treatment
The Moss Report on Liver Cancer begins with a discussion of conventional oncology’s understanding and treatment of this major form of cancer. This includes such topics as surgery, local ablative therapy, chemotherapy, targeted therapy, and other new treatments.

It discusses markers used to detect the existence and progression of the disease, and useful methods for determining whether or not a patient will benefit appreciably from various treatments. The main body of this Moss Report contains comprehensive, up-to-date information on conventional, integrative, experimental, complementary, CAM, dietary, and alternative cancer treatments and other matters of urgent concern to liver cancer patients.
We also discuss innovative and alternative treatment centers for treating liver cancer, in the US and abroad.
This 509-page report features a comprehensive discussion of the treatment and prevention of primary cancer of the liver – from the best techniques of surgery, radiation and chemotherapy to the latest complementary and alternative (CAM) approaches. New this year is a discussion of how science is harnessing the immune system in various ways to fight these cancers. This includes very encouraging results with “immune checkpoint inhibitors” such as nivolumab (Opdivo®) with an explanation of which liver cancer patients are likely to respond to this important new kind of treatment. There is also an up-to-the-minute discussion of adoptive immunotherapy and ablation.
No patient with HCC liver cancer or their loved ones should be without this outstanding resource.

Moss Reports e-book Alternative Cancer Therapies

Moss Report
Liver Cancer
E-book

$349

Moss Report printed icon Alternative Cancer Therapies

Moss Report
Liver Cancer
Printed Book

$379

Discounts and Savings Available

Purchase both the E-Book and
Printed Moss Report and save $100.*

Purchase a Moss Report and
Schedule a Consultation and save $100.*

If you are a Medical Professional and refer patients to Moss Reports, click here find out more about our advocate program.

*Discounts applied when purchased together at check-out.

“I can’t tell you what a wealth of information we found and how helpful and informative the Report was. Thank you. My eyes were truly opened.” — L. C.

“Thank you very much. Your report is very helpful and comprehensive.” —B. S.

“We have received your report.. and sincerely appreciate your thoroughness and writing style.” —R. D.

“I have really been disappointed with radiation and chemotherapy and have been so glad that you steered me to more viable alternatives.” —W. V.

“Thanks for your help. Your service is a marvelous resource, tremendously helpful for those of us sifting through the masses of information that we have to go through in these really stressful situations.” — S. A.

Read many more testimonials on this page.

Table of Contents

  • A QUICK GUIDE TO CAM CANCER TREATMENTS
  • GREEN LIGHT TREATMENTS: WELL RESEARCHED APPROACHES
  • AMBER LIGHT TREATMENTS FOR CANCER: EFFICACY AND SAFETY STILL UNCLEAR
  • RED LIGHT TREATMENTS: POORLY RESEARCHED (OR DOWNRIGHT DANGEROUS)
  • CONVENTIONAL TREATMENT SECTION
  • CAUSES AND INCIDENCE OF HCC
  • PRIMARY VS. SECONDARY LIVER CANCER
  • DIAGNOSIS AND TYPES OF HCC
  • OTHER KINDS OF PRIMARY LIVER CANCER
  • SYMPTOMS OF HCC
  • STAGING OF HCC
  • STAGE I
  • STAGE II
  • STAGE III
  • STAGE IV
  • NCCN RECOMMENDATIONS
  • TREATMENT OF PRIMARY LIVER CANCER (HCC)
  • SURGICAL OPTIONS
  • ORTHOTOPIC LIVER TRANSPLANTATION
  • LOCAL ABLATIVE THERAPY
  • CRYOSURGERY (CRYOABLATION)
  • PERCUTANEOUS ETHANOL INJECTION (PEI)
  • REGIONAL THERAPIES
  • EXTERNAL BEAM RADIATION THERAPY
  • SELECTIVE INTERNAL RADIATION THERAPY (SIRT)
  • HEPATIC ARTERY EMBOLIZATION (HAI)
  • TRANSARTERIAL CHEMOEMBOLIZATION (TACE) WITH BRIVANIB
  • CHEMOTHERAPY
  • ADJUVANT AND NEOADJUVANT CHEMOTHERAPY
  • SORAFENIB (NEXAVAR®)
  • THE STORM STUDY
  • REGIONAL CHEMOTHERAPY
  • ANTI-ANGIOGENIC AGENTS FOR LIVER CANCER
  • IMMUNE CHECKPOINT BLOCKADE (ICB)
  • NIVOLUMAB (OPDIVO®)
  • 2018 UPDATE: ADOPTIVE IMMUNOTHERAPY
  • “SONIC HEDGEHOG” INHIBITORS
  • ROSE BENGAL (PV-10®)
  • TOP SUPPLEMENTS (THE SHORT LIST)
  • ANTI-CANCER PLAN ON A TIGHT BUDGET
  • ANTI-CANCER RECIPES
  • THE HALLMARKS OF CANCER
  • A NEW MODEL FOR CANCER TREATMENT
  • INNOVATIVE SURGERY
  • INNOVATIVE RADIATION THERAPY
  • INNOVATIVE CHEMOTHERAPY
  • NAUSEA AND VOMITING
  • ACUPUNCTURE
  • BETA-GLUCANS
  • HYPNOSIS
  • MUSIC
  • MOUTH SORES (STOMATITIS)
  • ZINC SULFATE
  • NERVE PAIN
  • HAIR LOSS
  • CRAMPS
  • PICKLE JUICE REMEDY
  • CHEMOSENSITIVITY TESTING
  • TARGETED THERAPIES
  • PRECISION MEDICINE INITIATIVE
  • ANTI-ANGIOGENESIS DRUGS
  • MOLECULAR AND GENOMIC TESTING
  • CIRCULATING TUMOR CELLS (CELLSEARCH)
  • MONOCLONAL ANTIBODIES
  • IMMUNE CHECKPOINT BLOCKADE (ICB)
  • CANCER STEM CELLS (CSCS)
  • DIETARY COMPOUNDS THAT KILL CANCER STEM CELLS (CSCS)
  • PHYSICAL ACTIVITY AND EXERCISE
  • FASTING AND THE KETOGENIC DIET
  • A COST-FREE WAY TO PREVENT CANCER RECURRENCES
  • CALORIC RESTRICTION
  • PRACTICAL NOTES ON FASTING
  • TOP TEN SUPPLEMENTS (THE EXPOSITION)
  • FOOD AND CANCER PREVENTION
  • VITAMINS, MINERALS & ANTIOXIDANTS
  • THE CONCURRENT USE DEBATE
  • RADIOPROTECTION
  • CONCURRENT USE OF ANTIOXIDANTS AND RADIATION
  • HERBS, SPICES AND BOTANICALS
  • HYPERTHERMIA
  • CRYOABLATION
  • SOUND, LIGHT AND ELECTRICITY
  • CANCER IMMUNOTHERAPY
  • VIRAL THERAPY (ONCOLYTIC VIRUSES)
  • ELECTROACUPUNCTURE
  • DRUGS NEW AND OLD
  • INNOVATIVE CANCER CLINICS
  • FINDING AN INTEGRATIVE PHYSICIAN
  • INTEGRATIVE ONCOLOGY DEPARTMENTS
  • AMERICAN CLINICS
  • INTERNATIONAL CLINICSSUPPLEMENTS AND SURGERY
  • CAM AND FATIGUE
  • POPULAR BUT UNLIKELY TREATMENTS

You may also be interested in…

Phone Consultation
with Ralph W. Moss, PhD